RxDoctor Payments Data

Candace Parker-Autry, MD

Urogynecology and Reconstructive Pelvic Surgery · Winston Salem, NCNPI 1396800355

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,911 of the $2,399 with a category attached, or 79.6%. 10 manufacturers reported payments, led by Medtronic at 27.4% of the total. 2025 is the largest year on record at $737, 5.1 times the $144 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in NC, where the typical reported total is $4,140.

$2,399in general payments, 2019–2025

Across 33 payments — averaging $72.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$656
  • Coloplast$574
  • Axonics, Inc.$346
  • Boston Scientific$273
  • Novo Nordisk$194
  • Amarin Pharma, Inc.$105
  • plus $251 from 4 others

What the payments were for

  • Travel & lodging$48920%
  • Food & beverage$1,91180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,399 in reported general payments places this provider in the 40th percentile of 35 urogynecology and reconstructive pelvic surgery providers in North Carolina.

See all urogynecology and reconstructive pelvic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$90,075
Medicare patients
181
Services billed
1,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron123$76,543
PremarinEstrogens, Conjugated41$21,199
Estradiol326$20,781
GemtesaVibegron23$10,544
Trospium Chloride31$2,828
Darifenacin ErDarifenacin Hydrobromide20$2,103
Solifenacin Succinate43$1,535
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst79$1,288
Desmopressin Acetate15$411
Clobetasol Propionate19$361
Levonorgestrel-Eth EstradiolLevonorgestrel/Ethin.Estradiol11$238
Triamcinolone Acetonide12$222
Cephalexin17$127
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim47$124

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →